Good news for Merck: According to a new study, its cash cow vaccine, HPV-blocker Gardasil, isn't linked to an increased risk of multiple sclerosis--or any other similar CNS diseases, for that matter.
After 2014's growth spurt, Pfizer's vaccines unit is not done expanding. The pharma giant has grabbed privately held Swiss company Redvax for an undisclosed sum, adding a preclinical human cytomegalovirus (CMV) vaccine candidate and a tech platform and IP related to a second, undisclosed vaccine program.
Italy's drug regulator has a growing investigation on its hands, and Novartis is in the middle of it. The number of people who have died in the country after receiving one of the Swiss pharma giant's flu vaccines has risen by 10 just days after Italy issued a partial ban on the product.
Merck may soon be the next Big Pharma to step into the Ebola vaccine arena.
The U.K. and Novartis have been negotiating for months now on a fair price for the Swiss pharma's meningitis B shot, Bexsero, which the country plans to add to its childhood vaccination schedule. So what's the holdup?
After a lengthy strategic review and a handful of divestments, Novartis' slim-down effort is finally coming to a close. The company has sold off its flu vaccines business--the only piece of the vaccines unit it hung onto after a multibillion-dollar April transaction with GlaxoSmithKline--to Australia's CSL.
Hunting of infected boars is being blamed for the spread of African swine fever in Poland, Estonia, Latvia and Lithuania, according to a top European Commission animal health official, who also rebuffed claims the agency isn't doing enough to fight the virus.
Wisconsin-based Pan Genome Systems is looking for up to $2 million in funding to conduct trials for its live attenuated vaccine to combat Johne's disease.
Artes Biotechnology, InstrAction and Q-Biologicals have teamed to develop a virus-like particle vaccine platform for use in veterinary applications.
With the Ebola death toll mounting in West Africa, a Phase I trial of GlaxoSmithKline's experimental vaccine for the disease is underway at the U.S. National Institutes of Health.